SNGX

SOLIGENIX, INC.

Nasdaq · Pharmaceutical Preparations · Inc. DE · CIK 0000812796

$0.4300 0.00% $7.4M

Vol

Market Cap$7.4M

Cap SizeNano Cap

Inst. Holders6 funds

Inst. Value$136.9K

Inst. Activity2 buys / 0 sells

Reddit Sentiment63° Warm

SEC Reports3

Exchange Nasdaq·Sector Pharmaceutical Preparations·Inc. DE·CIK 0000812796·Prev Close $0.4300

Recent Activity

May 28, 2026 SEC

Soligenix filed an 8-K to increase the maximum aggregate offering amount under its existing at-the-market (ATM) equity f

8-K — Impact 5/10

May 28, 2026 SEC

Soligenix filed a 424B5 prospectus supplement to update the maximum dollar amount of common stock it can sell under its

424B5 — Impact 6/10

May 28, 2026 short_volume

Short Volume: SNGX — 55.9% short (4.5M / 8.1M)

Short: 4,526,088 | Exempt: 450,214 | TRF Vol: 8,098,903 | Short Ratio: 55.9% | Off-exchange volume (

Apr 3, 2026 SEC

Soligenix, Inc. (SNGX) has had four separate shelf registration statements (Forms S-3) become effective, allowing the co

EFFECT — Impact 6/10

Inst.

VANGUARD GROUP INC — ADD

85,468 shares ($114.5K)

Inst.

BANK OF AMERICA CORP — DOUBLED

88 shares ($118.00)

Price Targets

Historical data — last covering-analyst action Jul 2025. No current recommendation available.

$1.75 (Jul 2025)

Current $0.4300 Low $1.50 Median $1.75 High $2.00 2 analysts

$1.50 $2.00

Analyst Ratings

Historical distribution86% buy · 7 analysts · last covering-analyst action Jul 2025

2Strong Buy

4Buy

1Hold

0Sell

0Strong Sell

Historical Analyst Actions

Date	Firm	Action	Rating
Jul 16, 2025	Alliance Global Partners	MAINTAIN	Buy → Buy

Earnings Estimates

Period	EPS Est.	Range	Growth	#
Current Q	$-0.09 ▲ +50.0%	$-0.09 — $-0.09	89% YoY	1
Next Q	$-0.09 ▲ +57.1%	$-0.09 — $-0.09	84% YoY	1
Current FY	$-0.40 ▲ +52.9%	$-0.40 — $-0.40	81% YoY	1
Next FY	$-0.25 ▲ +70.6%	$-0.25 — $-0.25	38% YoY	1

Latest Reports

BEARISH 8-K 5/10

Soligenix filed an 8-K to increase the maximum aggregate offering amount under its existing at-the-market (ATM) equity f

May 28, 2026

BEARISH 424B5 6/10

Soligenix filed a 424B5 prospectus supplement to update the maximum dollar amount of common stock it can sell under its

May 28, 2026

Top Institutional Holders

Fund	Value	Move
VANGUARD CAPITAL MANAGEMENT LLC	$68.9K	—
VANGUARD FIDUCIARY TRUST CO	$63.6K	—
MORGAN STANLEY	$4.2K	DOUBLED
JONES FINANCIAL COMPANIES LLLP	$113.00	—
CITIGROUP INC	$22.00	—

Reddit Sentiment

63°

Warm

Bearish Neutral Bullish

4 mentions 3 bullish 1 bearish

6 institutional holders with $136.9K total value (116,031 shares) as of 2026-Q1. Top holders: VANGUARD, VANGUARD, MORGAN.

Top Institutional Holders — 2026-Q1

#	Fund	Shares	Value	% of Tracked	Last Move
1	VANGUARD CAPITAL MANAGEMENT LLC	58,400	$68.9K	50.3%	—
2	VANGUARD FIDUCIARY TRUST CO	53,914	$63.6K	46.5%	—
3	MORGAN STANLEY	3,592	$4.2K	3.1%	DOUBLED +1603.6%
4	JONES FINANCIAL COMPANIES LLLP	100	$113.00	0.1%	—
5	CITIGROUP INC	19	$22.00	0.0%	—
6	CWM, LLC	6	$7.00	0.0%	DOUBLED +500.0%

Recent Position Changes

Fund	Action	Prev Shares	Curr Shares	Change %	Value	Quarter
VANGUARD GROUP INC	ADD	52,522	85,468	+62.7%	$114.5K	2025-Q4
BANK OF AMERICA CORP /DE/	DOUBLED	35	88	+151.4%	$118.00	2025-Q4
UBS Group AG	NEAR_EXIT	19,423	183	-99.1%	$212.00	2025-Q3
UBS Group AG	ADD	10,469	19,423	+85.5%	$25.4K	2025-Q2
CWM, LLC	DOUBLED	1	6	+500.0%	—	2025-Q1
UBS Group AG	DOUBLED	313	10,469	+3244.7%	$22.5K	2025-Q1
MORGAN STANLEY	DOUBLED	224	3,816	+1603.6%	$10.3K	2024-Q4
BANK OF AMERICA CORP /DE/	ADD	11	19	+72.7%	$75.00	2024-Q3

∅

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

3 SEC filing reports analyzed. Sentiment: 0 bullish, 3 bearish, 0 mixed, 0 neutral. Avg impact: 5.7/10.

BEARISH 8-K 5/10

Soligenix filed an 8-K to increase the maximum aggregate offering amount under its existing at-the-m

May 28, 2026

BEARISH 424B5 6/10

Soligenix filed a 424B5 prospectus supplement to update the maximum dollar amount of common stock it

May 28, 2026

BEARISH EFFECT 6/10

Soligenix, Inc. (SNGX) has had four separate shelf registration statements (Forms S-3) become effect

Apr 3, 2026

∅

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Historical analyst distribution (last covering-analyst action Jul 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.

Analyst Price Targets

Historical data — last covering-analyst action Jul 2025. No current recommendation available.

$1.75 mean target (Jul 2025)

$1.50 Low $2.00 High

Metric	Value
Current Price	$0.4300
Target Low	$1.50
Target Mean	$1.75
Target Median	$1.75
Target High	$2.00
# Analysts	2
Recommendation	— (no recent coverage)

Earnings Estimates & Revisions

Period	EPS Avg	EPS Low	EPS High	EPS Growth	30d Rev.	Up/Down	Rev. Avg	Rev. Growth	Analysts
Current Q 2026-06-30	$-0.09	$-0.09	$-0.09	89.0%	+50.0%	1↑ 0↓	$0.0B	0.0%	1
Next Q 2026-09-30	$-0.09	$-0.09	$-0.09	84.5%	+57.1%	1↑ 0↓	$0.0B	0.0%	1
Current FY 2026-12-31	$-0.40	$-0.40	$-0.40	81.3%	+52.9%	1↑ 0↓	$0.0B	0.0%	1
Next FY 2027-12-31	$-0.25	$-0.25	$-0.25	37.5%	+70.6%	1↑ 0↓	$0.0B	0.0%	1

Current Quarter EPS Revision History

Timepoint	EPS Estimate	Change
Current	$-0.090
7d ago	$-0.180	+0.090
30d ago	$-0.180	+0.090
60d ago	$-0.180	+0.090
90d ago	$-0.180	+0.090

1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.

Historical Analyst Actions

Date	Analyst Firm	Action	Previous Rating	New Rating
Jul 16, 2025	Alliance Global Partners	MAINTAIN	Buy	Buy

Monthly Consensus History

Period	Strong Buy	Buy	Hold	Buy %
Jun 1, 2026	2	4	1	86%
May 1, 2026	2	4	1	86%
Apr 1, 2026	2	4	1	86%
Mar 1, 2026	2	4	1	86%
Feb 1, 2026	2	4	1	86%
Jan 1, 2026	2	4	1	86%

Strong BuyBuyHoldSellStrong Sell

∅

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

63°

Warm

Bearish Neutral Bullish

4 mentions 3 bullish 1 bearish 4 time periods

Reddit Sentiment History

Date	Mentions	Sentiment	Bullish	Bearish	Threads
May 28, 2026	1	60° Warm	1	0	1
Apr 20, 2026	1	40° Cool	0	1	1
Mar 28, 2026	1	60° Warm	1	0	1
Mar 28, 2026	1	60° Warm	1	0	1

Recent Reddit Threads

r/pennystocks Bullish 16d 2h ago

🚨 Ebola Virus Alert 🌍 As global health concerns rise again, biotech and diagnostic companies could see major attention from investors. 📈 Keeping an eye on:✅ CODX✅ SNGX

▲ 1 💬 0 ⚡ 0.5

r/pennystocks Bullish 16d 2h ago

🚨 Ebola Virus Alert 🌍 As global health concerns rise again, biotech and diagnostic companies could see major attention from investors. 📈 Keeping an eye on:✅ CODX✅ SNGX

▲ 1 💬 1 ⚡ 0.5

r/pennystocks Bearish 1mo ago

SNGX: With the imminent Phase 3 interim data coming soon, this is due for an aggressive re-rate

▲ 1 💬 0 ⚡ 0.5

r/pennystocks Bullish 2mo ago

Interesting analysis on SNGX

▲ 1 💬 1 ⚡ 0.5

May 28, 2026

short_volume

Short Volume: SNGX — 55.9% short (4.5M / 8.1M)

Short: 4,526,088 | Exempt: 450,214 | TRF Vol: 8,098,903 | Short Ratio: 55.9% | Off-exchange volume (dark pool + OTC)

May 26, 2026

short_volume

Short Volume: SNGX — 55.8% short (2.6M / 4.6M)

Short: 2,570,918 | Exempt: 47,972 | TRF Vol: 4,606,547 | Short Ratio: 55.8% | Off-exchange volume (dark pool + OTC)

May 8, 2026

short_volume

Short Volume: SNGX — 55.1% short (0.3M / 0.5M)

Short: 281,990 | Exempt: 1,001 | TRF Vol: 511,470 | Short Ratio: 55.1% | Off-exchange volume (dark pool + OTC)

May 7, 2026

earnings_calendar

SNGX Q1 2026 Earnings Scheduled — 2026-05-07

Apr 29, 2026

short_volume

Short Volume: SNGX — 56.4% short (1.2M / 2.1M)

Short: 1,185,976 | Exempt: 168,724 | TRF Vol: 2,101,317 | Short Ratio: 56.4% | Off-exchange volume (dark pool + OTC)

Apr 28, 2026

short_volume

Short Volume: SNGX — 57.5% short (5.1M / 8.8M)

Short: 5,066,851 | Exempt: 509,362 | TRF Vol: 8,812,689 | Short Ratio: 57.5% | Off-exchange volume (dark pool + OTC)

Mar 19, 2026

earnings_calendar

SNGX Q4 2025 Earnings After Market Close — 2026-03-19